BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 27542507)

  • 1. Quantitative body fluid proteomics in medicine - A focus on minimal invasiveness.
    Csősz É; Kalló G; Márkus B; Deák E; Csutak A; Tőzsér J
    J Proteomics; 2017 Feb; 153():30-43. PubMed ID: 27542507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Approaching clinical proteomics: current state and future fields of application in fluid proteomics.
    Apweiler R; Aslanidis C; Deufel T; Gerstner A; Hansen J; Hochstrasser D; Kellner R; Kubicek M; Lottspeich F; Maser E; Mewes HW; Meyer HE; Müllner S; Mutter W; Neumaier M; Nollau P; Nothwang HG; Ponten F; Radbruch A; Reinert K; Rothe G; Stockinger H; Tarnok A; Taussig MJ; Thiel A; Thiery J; Ueffing M; Valet G; Vandekerckhove J; Verhuven W; Wagener C; Wagner O; Schmitz G
    Clin Chem Lab Med; 2009; 47(6):724-44. PubMed ID: 19527139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human body fluid proteome analysis.
    Hu S; Loo JA; Wong DT
    Proteomics; 2006 Dec; 6(23):6326-53. PubMed ID: 17083142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of proteomics in the discovery of autism biomarkers.
    Al-Ayadhi L; Halepoto DM
    J Coll Physicians Surg Pak; 2013 Feb; 23(2):137-43. PubMed ID: 23374519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Comparative Proteomics Analysis of Five Body Fluids: Plasma, Urine, Cerebrospinal Fluid, Amniotic Fluid, and Saliva.
    Zhao M; Yang Y; Guo Z; Shao C; Sun H; Zhang Y; Sun Y; Liu Y; Song Y; Zhang L; Li Q; Liu J; Li M; Gao Y; Sun W
    Proteomics Clin Appl; 2018 Nov; 12(6):e1800008. PubMed ID: 29781159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SRM/MRM targeted proteomics as a tool for biomarker validation and absolute quantification in human urine.
    Mermelekas G; Vlahou A; Zoidakis J
    Expert Rev Mol Diagn; 2015; 15(11):1441-54. PubMed ID: 26472065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiplexing Biomarker Methods, Proteomics and Considerations for Alzheimer's Disease.
    Robinson RA; Amin B; Guest PC
    Adv Exp Med Biol; 2017; 974():21-48. PubMed ID: 28353223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disease Detection with Molecular Biomarkers: From Chemistry of Body Fluids to Nature-Inspired Chemical Sensors.
    Broza YY; Zhou X; Yuan M; Qu D; Zheng Y; Vishinkin R; Khatib M; Wu W; Haick H
    Chem Rev; 2019 Nov; 119(22):11761-11817. PubMed ID: 31729868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toward an integrated pipeline for protein biomarker development.
    Drabovich AP; Martínez-Morillo E; Diamandis EP
    Biochim Biophys Acta; 2015 Jun; 1854(6):677-86. PubMed ID: 25218201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteomics of human biological fluids for biomarker discoveries: technical advances and recent applications.
    Dayon L; Cominetti O; Affolter M
    Expert Rev Proteomics; 2022 Feb; 19(2):131-151. PubMed ID: 35466824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exosomes in bodily fluids are a highly stable resource of disease biomarkers.
    Boukouris S; Mathivanan S
    Proteomics Clin Appl; 2015 Apr; 9(3-4):358-67. PubMed ID: 25684126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Verification of protein biomarker specificity for the identification of biological stains by quadrupole time-of-flight mass spectrometry.
    Legg KM; Powell R; Reisdorph N; Reisdorph R; Danielson PB
    Electrophoresis; 2017 Mar; 38(6):833-845. PubMed ID: 27943336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteomics of human cerebrospinal fluid: discovery and verification of biomarker candidates in neurodegenerative diseases using quantitative proteomics.
    Kroksveen AC; Opsahl JA; Aye TT; Ulvik RJ; Berven FS
    J Proteomics; 2011 Apr; 74(4):371-88. PubMed ID: 21111852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of potential saliva and tear biomarkers in primary Sjögren's syndrome, utilising the extraction of extracellular vesicles and proteomics analysis.
    Aqrawi LA; Galtung HK; Vestad B; Øvstebø R; Thiede B; Rusthen S; Young A; Guerreiro EM; Utheim TP; Chen X; Utheim ØA; Palm Ø; Jensen JL
    Arthritis Res Ther; 2017 Jan; 19(1):14. PubMed ID: 28122643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unraveling the molecular repertoire of tears as a source of biomarkers: beyond ocular diseases.
    Pieragostino D; D'Alessandro M; di Ioia M; Di Ilio C; Sacchetta P; Del Boccio P
    Proteomics Clin Appl; 2015 Feb; 9(1-2):169-86. PubMed ID: 25488355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-accuracy proteome maps of human body fluids.
    Schmidt A; Aebersold R
    Genome Biol; 2006; 7(11):242. PubMed ID: 17140426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MS-Based Proteomics of Body Fluids: The End of the Beginning.
    Bader JM; Albrecht V; Mann M
    Mol Cell Proteomics; 2023 Jul; 22(7):100577. PubMed ID: 37209816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteome analysis of body fluids for amyotrophic lateral sclerosis biomarker discovery.
    Krüger T; Lautenschläger J; Grosskreutz J; Rhode H
    Proteomics Clin Appl; 2013 Jan; 7(1-2):123-35. PubMed ID: 23129563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent applications of CE- and HPLC-MS in the analysis of human fluids.
    Iadarola P; Fumagalli M; Bardoni AM; Salvini R; Viglio S
    Electrophoresis; 2016 Jan; 37(1):212-30. PubMed ID: 26426542
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.